REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Brady Pharma Inc. (Philippines)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Scheduled Passenger Air Transportation | Other Support Activities for Transportation
Full name: Brady Pharma Inc. Profile Updated: March 05, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Brady Pharma Inc. is based in Philippines. The head office is in Mandaluyong. The enterprise operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. It was incorporated on November 03, 2010.

Headquarters
281 Bendel Center, Edsa
Mandaluyong; National Capital Region; Postal Code: 1550

Contact Details: Purchase the Brady Pharma Inc. report to view the information.

Basic Information
Financial Auditors:
Purchase the Brady Pharma Inc. report to view the information.
Incorporation Date:
November 03, 2010
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
President, Chairman
Purchase this report to view the information.
Director, Company Secretary
Purchase this report to view the information.
Treasurer, Director
Ownership Details
Purchase this report to view the information.
66%
Purchase this report to view the information.
18%
Purchase this report to view the information.
10%
Purchase this report to view the information.
3.8%
Purchase this report to view the information.
2%
Company Performance
Financial values in the chart are available after Brady Pharma Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Total Operating Revenue
-7.52%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo